West Pharmaceutical Services, Inc. (FRA:WPS)
242.10
+9.00 (3.86%)
At close: Dec 4, 2025
FRA:WPS Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 3, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 17,330 | 22,914 | 23,570 | 16,303 | 30,551 | 17,122 | Upgrade
|
| Market Cap Growth | -16.68% | -2.79% | 44.57% | -46.63% | 78.43% | 72.75% | Upgrade
|
| Enterprise Value | 17,050 | 22,737 | 23,035 | 15,902 | 30,223 | 16,967 | Upgrade
|
| Last Close Price | 240.00 | 315.68 | 316.50 | 220.67 | 406.12 | 223.19 | Upgrade
|
| PE Ratio | 41.35 | 48.15 | 43.91 | 29.74 | 52.50 | 60.50 | Upgrade
|
| PS Ratio | 6.74 | 8.20 | 8.83 | 6.04 | 12.27 | 9.76 | Upgrade
|
| PB Ratio | 6.66 | 8.84 | 9.04 | 6.49 | 14.88 | 11.29 | Upgrade
|
| P/TBV Ratio | 6.93 | 9.25 | 9.45 | 6.81 | 15.78 | 12.23 | Upgrade
|
| P/FCF Ratio | 53.64 | 85.83 | 62.86 | 39.65 | 105.09 | 70.26 | Upgrade
|
| P/OCF Ratio | 29.31 | 36.31 | 33.55 | 24.07 | 59.49 | 44.33 | Upgrade
|
| EV/Sales Ratio | 6.57 | 8.14 | 8.63 | 5.89 | 12.14 | 9.67 | Upgrade
|
| EV/EBITDA Ratio | 23.22 | 31.43 | 30.19 | 19.22 | 38.58 | 39.03 | Upgrade
|
| EV/EBIT Ratio | 30.57 | 39.66 | 36.05 | 22.25 | 44.72 | 49.11 | Upgrade
|
| EV/FCF Ratio | 52.77 | 85.17 | 61.43 | 38.68 | 103.97 | 69.62 | Upgrade
|
| Debt / Equity Ratio | 0.10 | 0.11 | 0.11 | 0.12 | 0.14 | 0.18 | Upgrade
|
| Debt / EBITDA Ratio | 0.36 | 0.39 | 0.35 | 0.35 | 0.36 | 0.60 | Upgrade
|
| Debt / FCF Ratio | 0.80 | 1.11 | 0.75 | 0.72 | 0.98 | 1.11 | Upgrade
|
| Asset Turnover | 0.78 | 0.77 | 0.79 | 0.83 | 0.93 | 0.84 | Upgrade
|
| Inventory Turnover | 4.63 | 4.67 | 4.28 | 4.41 | 4.73 | 4.95 | Upgrade
|
| Quick Ratio | 2.02 | 1.93 | 2.07 | 2.73 | 2.13 | 1.99 | Upgrade
|
| Current Ratio | 2.87 | 2.80 | 2.88 | 3.70 | 2.93 | 2.73 | Upgrade
|
| Return on Equity (ROE) | 16.95% | 17.71% | 21.32% | 23.34% | 31.59% | 20.20% | Upgrade
|
| Return on Assets (ROA) | 10.22% | 9.93% | 11.86% | 13.78% | 15.73% | 10.29% | Upgrade
|
| Return on Capital (ROIC) | 12.40% | 12.01% | 14.25% | 16.86% | 19.82% | 12.92% | Upgrade
|
| Return on Capital Employed (ROCE) | 18.30% | 19.20% | 22.40% | 24.70% | 28.30% | 18.50% | Upgrade
|
| Earnings Yield | 2.42% | 2.08% | 2.28% | 3.36% | 1.91% | 1.65% | Upgrade
|
| FCF Yield | 1.86% | 1.17% | 1.59% | 2.52% | 0.95% | 1.42% | Upgrade
|
| Dividend Yield | 0.31% | 0.25% | 0.22% | 0.31% | 0.15% | 0.24% | Upgrade
|
| Payout Ratio | 13.18% | 12.00% | 9.61% | 9.23% | 7.72% | 13.89% | Upgrade
|
| Buyback Yield / Dilution | 1.55% | 2.13% | 0.66% | 0.66% | -0.66% | -0.53% | Upgrade
|
| Total Shareholder Return | 1.87% | 2.37% | 0.88% | 0.97% | -0.51% | -0.29% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.